However, growing evidence from experimental and clinical studies indicate that microparticles expressing tissue factor (TF), shed from cancer cells and activated or apoptotic leukocytes, especially monocytes, may play an important role in the pathogenesis of cancer-related venous thrombosis [25–27]. The gene discussed is TF; the disease is Venous thrombosis.